Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94320612 | 9432061 | 2 | F | 201307 | 20130813 | 20130731 | 20130816 | PER | US-VERTEX PHARMACEUTICALS INC-2013-008372 | VERTEX | 69.55 | YR | M | Y | 0.00000 | 20130816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94320612 | 9432061 | 1 | PS | VX-950 (Telaprevir) | 1 | ORAL | UNK | D | 201917 | TABLET | |||||||||
| 94320612 | 9432061 | 2 | SS | RIBAVIRIN | 1 | UNK | D | 0 | |||||||||||
| 94320612 | 9432061 | 3 | SS | PEGASYS | 1 | UNK | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94320612 | 9432061 | 1 | Hepatitis C |
| 94320612 | 9432061 | 2 | Hepatitis C |
| 94320612 | 9432061 | 3 | Hepatitis C |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94320612 | 9432061 | Decreased appetite | |
| 94320612 | 9432061 | Dizziness | |
| 94320612 | 9432061 | Fatigue | |
| 94320612 | 9432061 | Nausea | |
| 94320612 | 9432061 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 94320612 | 9432061 | 1 | 20130709 | 0 | ||
| 94320612 | 9432061 | 2 | 20130709 | 0 | ||
| 94320612 | 9432061 | 3 | 20130709 | 0 |